$HSTM
HEALTHSTREAM INC

2017 Q4 Form 10-Q Financial Statement

#000119312517324994 Filed on October 30, 2017

View on sec.gov

Income Statement

Concept 2017 Q4 2017 Q3 2016 Q4
Revenue $55.27M $63.55M $24.89M
YoY Change 122.06% 8.89% -55.45%
Cost Of Revenue $22.31M $26.73M $4.560M
YoY Change 389.25% 7.4% -80.7%
Gross Profit $32.96M $36.82M $20.33M
YoY Change 62.12% 9.99% -36.92%
Gross Profit Margin 59.63% 57.94% 81.68%
Selling, General & Admin $19.06M $17.52M $12.15M
YoY Change 56.87% -8.65% -32.31%
% of Gross Profit 57.83% 47.58% 59.76%
Research & Development $6.220M $6.990M $2.710M
YoY Change 129.52% -3.73% -64.15%
% of Gross Profit 18.87% 18.98% 13.33%
Depreciation & Amortization $6.180M $6.570M $4.390M
YoY Change 40.77% 14.16% -9.48%
% of Gross Profit 18.75% 17.84% 21.59%
Operating Expenses $31.45M $6.990M $19.24M
YoY Change 63.46% -3.73% -36.63%
Operating Profit $1.510M $3.982M $1.090M
YoY Change 38.53% 209.64% -41.71%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $250.0K $173.0K $120.0K
YoY Change 108.33% -48.66% -29.41%
Pretax Income $1.760M $4.155M $1.200M
YoY Change 46.67% 156.01% -41.46%
Income Tax $290.0K $1.651M $470.0K
% Of Pretax Income 16.48% 39.74% 39.17%
Net Earnings $3.950M $2.504M -$310.0K
YoY Change -1374.19% 115.49% -117.13%
Net Earnings / Revenue 7.15% 3.94% -1.25%
Basic Earnings Per Share $0.08
Diluted Earnings Per Share $122.5K $0.08 -$9.767K
COMMON SHARES
Basic Shares Outstanding 31.90M shares 31.89M shares 31.74M shares
Diluted Shares Outstanding 32.22M shares

Balance Sheet

Concept 2017 Q4 2017 Q3 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $131.1M $123.4M $103.2M
YoY Change 27.05% 22.66% -30.74%
Cash & Equivalents $84.77M $60.46M $49.63M
Short-Term Investments $46.35M $62.90M $53.50M
Other Short-Term Assets $8.330M $8.526M $8.694M
YoY Change -4.19% 12.42% 6.43%
Inventory
Prepaid Expenses
Receivables $36.69M $38.38M $44.81M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $199.7M $189.3M $177.4M
YoY Change 12.56% 9.36% -15.32%
LONG-TERM ASSETS
Property, Plant & Equipment $8.092M $9.923M $10.25M
YoY Change -21.02% -4.61% -17.85%
Goodwill $86.14M $110.3M $85.61M
YoY Change 0.62% 0.46% 3.06%
Intangibles
YoY Change
Long-Term Investments $3.800M $3.800M $3.300M
YoY Change 15.15% 15.15% -8.33%
Other Assets $754.0K $699.0K $603.0K
YoY Change 25.04% -27.49% -34.95%
Total Long-Term Assets $211.4M $214.6M $218.6M
YoY Change -3.28% -2.9% 28.54%
TOTAL ASSETS
Total Short-Term Assets $199.7M $189.3M $177.4M
Total Long-Term Assets $211.4M $214.6M $218.6M
Total Assets $411.1M $403.8M $396.0M
YoY Change 3.82% 2.48% 4.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.178M $15.20M $3.127M
YoY Change 33.61% 313.61% -32.26%
Accrued Expenses $9.567M $13.00M $8.146M
YoY Change 17.44% 22.38% 16.32%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $101.1M $94.74M $94.97M
YoY Change 6.42% -0.52% 6.61%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.048M $1.497M $1.095M
YoY Change -4.29% 92.42% 3.5%
Total Long-Term Liabilities $1.048M $1.497M $1.095M
YoY Change -4.29% 92.42% 3.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $101.1M $94.74M $94.97M
Total Long-Term Liabilities $1.048M $1.497M $1.095M
Total Liabilities $102.1M $96.24M $96.07M
YoY Change 6.3% 0.23% 6.58%
SHAREHOLDERS EQUITY
Retained Earnings $17.54M $13.59M $5.346M
YoY Change 228.13% 140.3% 236.02%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $300.2M $295.7M $286.1M
YoY Change
Total Liabilities & Shareholders Equity $411.1M $403.8M $396.0M
YoY Change 3.82% 2.48% 4.33%

Cashflow Statement

Concept 2017 Q4 2017 Q3 2016 Q4
OPERATING ACTIVITIES
Net Income $3.950M $2.504M -$310.0K
YoY Change -1374.19% 115.49% -117.13%
Depreciation, Depletion And Amortization $6.180M $6.570M $4.390M
YoY Change 40.77% 14.16% -9.48%
Cash From Operating Activities $11.05M $12.62M $9.250M
YoY Change 19.46% -14.09% -1.6%
INVESTING ACTIVITIES
Capital Expenditures -$2.800M -$3.670M -$2.850M
YoY Change -1.75% 7.94% -29.1%
Acquisitions
YoY Change
Other Investing Activities $15.97M -$3.110M $3.810M
YoY Change 319.16% -92.01% -61.55%
Cash From Investing Activities $13.17M -$6.780M $960.0K
YoY Change 1271.87% -83.99% -83.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 90.00K 70.00K -390.0K
YoY Change -123.08% -89.23% -45.83%
NET CHANGE
Cash From Operating Activities 11.05M 12.62M 9.250M
Cash From Investing Activities 13.17M -6.780M 960.0K
Cash From Financing Activities 90.00K 70.00K -390.0K
Net Change In Cash 24.31M 5.910M 9.820M
YoY Change 147.56% -121.89% -32.6%
FREE CASH FLOW
Cash From Operating Activities $11.05M $12.62M $9.250M
Capital Expenditures -$2.800M -$3.670M -$2.850M
Free Cash Flow $13.85M $16.29M $12.10M
YoY Change 14.46% -9.95% -9.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39820000
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1623000
CY2017Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
12997000
CY2017Q3 us-gaap Assets Current
AssetsCurrent
189275000
CY2017Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
38379000
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24470000
CY2017Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
15235000
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-20000
CY2017Q3 us-gaap Assets
Assets
403840000
CY2017Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
62943000
CY2017Q3 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
39099000
CY2017Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
18685000
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60460000
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31896000 shares
CY2017Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
282083000
CY2017Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31896000 shares
CY2017Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
66509000
CY2017Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
4871000
CY2017Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
7074000
CY2017Q3 us-gaap Goodwill
Goodwill
110298000
CY2017Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
3771000
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
403840000
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
94741000
CY2017Q3 us-gaap Other Assets Current
OtherAssetsCurrent
8526000
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
699000
CY2017Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1497000
CY2017Q3 us-gaap Prepaid Royalties
PrepaidRoyalties
17221000
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9923000
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
13594000
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
295657000
CY2017Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
1746000
CY2017Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31896317 shares
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
82010000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
863000
CY2016Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
13161000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
177437000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44805000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20527000
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
13267000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-51000
CY2016Q4 us-gaap Assets
Assets
396000000
CY2016Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
53540000
CY2016Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
31787000
CY2016Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
16310000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49634000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31748000 shares
CY2016Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
280813000
CY2016Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31748000 shares
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
68542000
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5968000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
7859000
CY2016Q4 us-gaap Goodwill
Goodwill
109765000
CY2016Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
3276000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
396000000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
94970000
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
8694000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
603000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1095000
CY2016Q4 us-gaap Prepaid Royalties
PrepaidRoyalties
18183000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10245000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5346000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
286108000
CY2016Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2581000
dei Amendment Flag
AmendmentFlag
false
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1358000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
68000 shares
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1358000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10826000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6087000
us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
79382000
us-gaap Costs And Expenses
CostsAndExpenses
176233000
us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
2192000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
710000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19488000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.337 pure
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Type
DocumentType
10-Q
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
dei Document Period End Date
DocumentPeriodEndDate
2017-09-30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
dei Entity Registrant Name
EntityRegistrantName
HEALTHSTREAM INC
dei Entity Central Index Key
EntityCentralIndexKey
0001095565
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9139000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2479000
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
91000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2770000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
96000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
335000 shares
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3083000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-169000
us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
-962000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-5301000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-24749000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
35663000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-88000
us-gaap Net Income Loss
NetIncomeLoss
6056000
us-gaap Operating Income Loss
OperatingIncomeLoss
8671000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
31000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
31000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
25622000
us-gaap Other Noncash Expense
OtherNoncashExpense
365000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
468000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
410000
us-gaap Payments For Software
PaymentsForSoftware
9213000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5312000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
79290000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
69566000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
322000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
963000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20630000
us-gaap Sales Revenue Net
SalesRevenueNet
184904000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
31111000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-88000
dei Trading Symbol
TradingSymbol
HSTM
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32183000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31848000 shares
hstm Payments To Acquire Cost Method Investments
PaymentsToAcquireCostMethodInvestments
500000
hstm Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
3 Incentive_Plan
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1516000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
42000 shares
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-42190000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4109000
us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
70410000
us-gaap Costs And Expenses
CostsAndExpenses
161149000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
791000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15976000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.380 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
661000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
661000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6553000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1766000
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
4415000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-898000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
36000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
336000 shares
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
134000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2487000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
326000
us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
2291000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
6855000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-57617000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
14983000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
444000
us-gaap Net Income Loss
NetIncomeLoss
4066000
us-gaap Operating Income Loss
OperatingIncomeLoss
6088000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
43000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
43000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
25396000
us-gaap Other Noncash Expense
OtherNoncashExpense
846000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
465000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
311000
us-gaap Payments For Software
PaymentsForSoftware
7070000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
53078000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3870000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
82771000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
88197000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
975000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
94000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
340000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21524000
us-gaap Sales Revenue Net
SalesRevenueNet
167237000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
27843000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32050000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31714000 shares
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
512000
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21000 shares
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1149000
CY2016Q3 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
24889000
CY2016Q3 us-gaap Costs And Expenses
CostsAndExpenses
57081000
CY2016Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5755000
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1623000
CY2016Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
368000 shares
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
461000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
1162000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1286000
CY2016Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-13000
CY2016Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-13000
CY2016Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
8891000
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
337000
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7261000
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
58367000
CY2016Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10285000
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32107000 shares
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31739000 shares
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
440000
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
31000 shares
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2520000
CY2017Q3 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
26731000
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2017Q3 us-gaap Costs And Expenses
CostsAndExpenses
59571000
CY2017Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6570000
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4155000
CY2017Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
324000 shares
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1651000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
2504000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3982000
CY2017Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
16000
CY2017Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
16000
CY2017Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
9163000
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
173000
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6990000
CY2017Q3 us-gaap Sales Revenue Net
SalesRevenueNet
63553000
CY2017Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10117000
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32217000 shares
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31893000 shares

Files In Submission

Name View Source Status
0001193125-17-324994-index-headers.html Edgar Link pending
0001193125-17-324994-index.html Edgar Link pending
0001193125-17-324994.txt Edgar Link pending
0001193125-17-324994-xbrl.zip Edgar Link pending
d426779d10q.htm Edgar Link pending
d426779dex311.htm Edgar Link pending
d426779dex312.htm Edgar Link pending
d426779dex321.htm Edgar Link pending
d426779dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hstm-20170930.xml Edgar Link completed
hstm-20170930.xsd Edgar Link pending
hstm-20170930_cal.xml Edgar Link unprocessable
hstm-20170930_def.xml Edgar Link unprocessable
hstm-20170930_lab.xml Edgar Link unprocessable
hstm-20170930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending